Month: December 2020

Myovant Sciences Announces FDA Approval of ORGOVYX™ (relugolix), the First and Only Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

‘Vials of Hope’ Arrive at Genesis HealthCare-Affiliated Reservoir Center as Nursing Home Residents and Healthcare Workers Begin COVID-19 Vaccinations in Connecticut

KENNETT SQUARE, Pa., Dec. 18, 2020 (GLOBE NEWSWIRE) -- Residents and healthcare workers at The Reservoir Center, a Genesis HealthCare-...

Tauriga Sciences Inc. Enters into Master Services Agreement with CSTI to Resume the Clinical Development of its Anti-Nausea Pharmaceutical Grade Version of Tauri-Gum

The Company’s Proposed Pharma Grade Version of Tauri-Gum™ is Being Developed Specifically to Target: Patients Subjected to Ongoing Chemotherapy Treatment...

Misonix Announces the Second Largest U.S. Commercial Payer Has Provided Coverage for TheraSkin® to Treat All Lower Extremity Dermal Wounds Adding 32 Million New Covered Lives

FARMINGDALE, N.Y., Dec. 18, 2020 (GLOBE NEWSWIRE) -- 2020) – Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic...

error: Content is protected !!